Skip to main navigation Skip to search Skip to main content

Sensor-augmented pump therapy lowers HbA(1c) in suboptimally controlled Type 1 diabetes; a randomized controlled trial

J Hermanides, K Nørgaard, D Bruttomesso, Christophe John Mathieu, A Frid, C M Dayan, P Diem, C Fermon, I M E Wentholt, J B L Hoekstra, J H DeVries

160 Citations (Scopus)

Abstract

To investigate the efficacy of sensor-augmented pump therapy vs. multiple daily injection therapy in patients with suboptimally controlled Type 1 diabetes.
Original languageEnglish
JournalDiabetic Medicine
Volume28
Issue number10
Pages (from-to)1158-67
Number of pages10
ISSN0742-3071
DOIs
Publication statusPublished - Nov 2011

Keywords

  • Adult
  • Blood Glucose
  • Diabetes Mellitus, Type 1
  • Equipment Design
  • Europe
  • Hemoglobin A, Glycosylated
  • Humans
  • Hypoglycemia
  • Hypoglycemic Agents
  • Infusion Pumps, Implantable
  • Injections
  • Insulin
  • Insulin Infusion Systems
  • Male
  • Middle Aged
  • Treatment Outcome
  • Young Adult

Fingerprint

Dive into the research topics of 'Sensor-augmented pump therapy lowers HbA(1c) in suboptimally controlled Type 1 diabetes; a randomized controlled trial'. Together they form a unique fingerprint.

Cite this